News and Announcements
Altech Chemicals Capital Raising Update July 2016
- Published July 22, 2016 3:44PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
22nd July 2016, ASX Announcement
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) advises that further to the suspension in trading of the Company’s securities on the Australian Securities Exchange (ASX) pre-open this morning, Perth stockbroking firm DJ Carmichael Pty Ltd (Lead Manager) and Hong Kong stockbroking firm Empire Capital Partners (Co-Manager) are arranging a placement of fully paid ordinary shares of the Company to a variety of professional and sophisticated investors (the Placement).
Funds raised by the Placement will be applied to the detailed design of the Company’s proposed high purity alumina (HPA) plant at Johor, Malaysia, the completion of debt financing for the project and for general working capital purposes.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
